Not applicableStudy completedNCT06353958What this trial is testingMiSaver® Stem Cell Treatment for Acute Myocardial InfarctionWho this might be right forAcute Myocardial Infarction Honya Medical Inc 30
Not applicableUnknownNCT04511182What this trial is testingEarly Individualized-Exercise Based Cardiac Rehabilitation Programs in Patients With Acute Myocardial InfarctionWho this might be right forAcute Myocardial Infarction RenJi Hospital 160
Large-scale testing (Phase 3)WithdrawnNCT02803073What this trial is testingEffect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After a Recent Myocardial InfarctionWho this might be right forHypogonadismAcute Myocardial Infarction: Rehabilitation Phase Texas Tech University Health Sciences Center
Not applicableStudy completedNCT02439294What this trial is testingImpact of the Obstructive Sleep Apnea Syndrome (OSAS) on the Ventricular Remodeling After Acute Myocardial InfarctionWho this might be right forRecent Acute Myocardial Infarction University Hospital, Montpellier 67
Large-scale testing (Phase 3)Enrolling By InvitationNCT04957719What this trial is testingSelatogrel Outcome Study in Suspected Acute Myocardial InfarctionWho this might be right forAcute Myocardial Infarction Viatris Innovation GmbH 25,000
Not applicableStudy completedNCT04309994What this trial is testingCombined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Urgent Isolated CABG Using MiECC in Patients With Recent Acute Myocardial InfarctionWho this might be right forHeart AttackCardioplegia Solution Adverse ReactionCoronary Artery Bypass Grafting (CABG) University Hospital, Basel, Switzerland 307
Testing effectiveness (Phase 2)WithdrawnNCT00691834What this trial is testingSafety and Efficacy on Cell-based Therapy in Patients With Recent Large Acute Myocardial InfarctionWho this might be right forAcute Myocardial InfarctionHeart Failure Duke University
Testing effectiveness (Phase 2)UnknownNCT00555828What this trial is testingSafety Study of Allogeneic Mesenchymal Precursor Cells (MPCs) in Subjects With Recent Acute Myocardial InfarctionWho this might be right forMyocardial Infarction Angioblast Systems 25
Post-approval studies (Phase 4)Looking for participantsNCT05759078What this trial is testingEffect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTionWho this might be right forMyocardial Infarction, Acute Wroclaw Medical University 1,000
Post-approval studies (Phase 4)Study completedNCT02415400What this trial is testingApixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the HeartWho this might be right forAcute Coronary Syndromes Bristol-Myers Squibb 4,614
Large-scale testing (Phase 3)Not Yet RecruitingNCT07625306What this trial is testingLp(a) Lowering Study of Pelacarsen (TQJ230) in Patients in the US With Elevated Lp(a) and Recent ACS (STEMI/NSTEMI) - Lp(a)FRONTIERS PEARLWho this might be right forAcute Coronary Syndrome (ACS) Novartis Pharmaceuticals 240
Early research (Phase 1)Looking for participantsNCT07619885What this trial is testingThe Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix® in Healthy ParticipantsWho this might be right forAcute Coronary Syndromes (ACS)Recent Myocardial InfarctionRecent Stroke+1 more Shanghai CureGene Pharmaceutical Co., Ltd. 136
Not applicableStudy completedNCT01340716What this trial is testingEffects of Tai Chi Chuan in Patients After Recent Acute Myocardial InfarctionWho this might be right forAcute Myocardial Infarction Hospital de Clinicas de Porto Alegre 61
Large-scale testing (Phase 3)Study completedNCT00809965What this trial is testingAn Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary SyndromeWho this might be right forAcute Coronary SyndromeMyocardial InfarctionMyocardial Ischemia+1 more Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 15,526